Dec 18, 2013, 11.20 AM | Source: CNBC-TV18
Tirthankar Patnaik, Director - Institutional Research at Religare Capital Markets is overweight on IT and pharma stocks.
Tirthankar Patnaik (more)
India Strategist, Mizuho Bank | Capital Expertise: Equity - Fundamental
He further added, "On financials, while we are talking about a peaking on rates we remain very concerned on asset quality. We don't know if the ramifications have really worked out in the system. So we would not be positive on financials at least until we see Q3 earnings come out. We remain underweight on financials. We are neutral on telecom and metals while marginally positive on consumer durables and negative on consumer staples."
"So all in all a defensive quality focused portfolio which might trail the benchmark if market does move meaningfully from current levels, but would stand us in good state if inflation does prove as chronic as we feel it would be," Patnaik said.
Maruti Suzuki may slip to Rs 3300-3400, says Jai Bala
Jai Bala of Cashthechaos.com feels that Maruti Suz
Look at Cadila Healthcare, Dishman Pharma: Jai Bala
Jai Bala of Cashthechaos.com is of the view that o
Avoid aviation space, says Ratnesh Kumar
Ratnesh Kumar, Market Expert is of the view that o
Reliance Industries may go above Rs 1100: Jai Bala
Jai Bala of Cashthechaos.com feels that Reliance I
Positive on IT space, says Ratnesh Kumar
Ratnesh Kumar, Market Expert is positive on IT spa
HCL Technologies may move to Rs 1100, says Jai Bala
Jai Bala of Cashthechaos.com feels that HCL Techno
Fundamental support for mkt missing; like banks: Mizuho Bank
Speaking to CNBC-TV18, Tithankar Patnaik of Mizuho
See further pain for mkt, no intraday trade in Bank Nifty: Pros
We are not in a mild recession but from a macro pe